StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.48−0.14 (-8.64%)

Close on Nov 16, 2026Market cap $55.39MP/E –Yield –

Tenax Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Tenax Therapeutics's total assets was $121.66M at Jun 30, 2026. For fiscal 2025 it was $104.23M, up 7.8% from the year before. Over ten years it grew 1.1% a year on average. The highest annual figure on record is $104.23M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$104.23M+7.8%
FY2024Dec 31, 2024$96.69M+727.4%
FY2023Dec 31, 2023$11.69M+243.2%
FY2022Dec 31, 2022$3.40M-43.2%
FY2021Dec 31, 2021$5.99M-12.8%
FY2020Dec 31, 2020$6.87M+7.9%
FY2019Dec 31, 2019$6.37M-52.3%
FY2018Dec 31, 2018$13.34M+34.8%
FY2017Dec 31, 2017$9.89M-88.1%
FY2015Apr 30, 2015$82.91M-11.3%
FY2014Apr 30, 2014$93.43M+2837.4%
FY2013Apr 30, 2013$3.18M-23.2%
FY2012Apr 30, 2012$4.14M+41.7%
FY2011Apr 30, 2011$2.92M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$121.66M+14.9%
Q1 FY2026CQ1 2026Mar 31, 2026$123.18M+9.9%
Q4 FY2025CQ4 2025Dec 31, 2025$104.23M+7.8%
Q3 FY2025CQ3 2025Sep 30, 2025$102.81M+3.0%
Q2 FY2025CQ2 2025Jun 30, 2025$105.86M+897.1%
Q1 FY2025CQ1 2025Mar 31, 2025$112.06M+674.9%
Q4 FY2024CQ4 2024Dec 31, 2024$96.69M+727.4%
Q3 FY2024CQ3 2024Sep 30, 2024$99.78M+739.3%
Q2 FY2024CQ2 2024Jun 30, 2024$10.62M-24.4%
Q1 FY2024CQ1 2024Mar 31, 2024$14.46M-5.3%
Q4 FY2023CQ4 2023Dec 31, 2023$11.69M+243.2%
Q3 FY2023CQ3 2023Sep 30, 2023$11.89M+150.9%
Q2 FY2023CQ2 2023Jun 30, 2023$14.05M+68.1%
Q1 FY2023CQ1 2023Mar 31, 2023$15.27M+308.6%
Q4 FY2022CQ4 2022Dec 31, 2022$3.40M-43.2%
Q3 FY2022CQ3 2022Sep 30, 2022$4.74M-46.8%
Q2 FY2022CQ2 2022Jun 30, 2022$8.36M+189.6%
Q1 FY2022CQ1 2022Mar 31, 2022$3.74M-18.0%
Q4 FY2021CQ4 2021Dec 31, 2021$5.99M-12.8%
Q3 FY2021CQ3 2021Sep 30, 2021$8.91M-0.9%
Q2 FY2021CQ2 2021Jun 30, 2021$2.89M-46.1%
Q1 FY2021CQ1 2021Mar 31, 2021$4.56M-23.4%
Q4 FY2020CQ4 2020Dec 31, 2020$6.87M+7.9%
Q3 FY2020CQ3 2020Sep 30, 2020$9.00M+15.7%
Q2 FY2020CQ2 2020Jun 30, 2020$5.35M-44.6%
Q1 FY2020CQ1 2020Mar 31, 2020$5.95M-48.0%
Q4 FY2019CQ4 2019Dec 31, 2019$6.37M-52.3%
Q3 FY2019CQ3 2019Sep 30, 2019$7.77M+42.5%
Q2 FY2019CQ2 2019Jun 30, 2019$9.66M+37.6%
Q1 FY2019CQ1 2019Mar 31, 2019$11.46M+37.8%
Q4 FY2018CQ4 2018Dec 31, 2018$13.34M+34.8%
Q3 FY2018CQ3 2018Sep 30, 2018$5.45M-50.4%
Q2 FY2018CQ2 2018Jun 30, 2018$7.03M-47.8%
Q1 FY2018CQ1 2018Mar 31, 2018$8.31M-56.6%
Q4 FY2017CQ4 2017Dec 31, 2017$9.89M-88.1%
Q3 FY2017CQ3 2017Sep 30, 2017$11.00M-87.2%
Q2 FY2017CQ2 2017Jun 30, 2017$13.45M–
Q1 FY2017CQ1 2017Mar 31, 2017$19.15M–
Q4 FY2015CQ1 2015Apr 30, 2015$82.91M–
Q3 FY2015CQ4 2014Jan 31, 2015$86.19M–

More Tenax Therapeutics figures

See a number that looks wrong?